Biotechnologies: the investment climate is favorable
Venture financing of biopharmaceutical startups does not stop, although with a smaller scale of cash injections.
18.07.2017Venture financing of biopharmaceutical startups does not stop, although with a smaller scale of cash injections.
18.07.2017Korea is the first foreign market where ExoaThlet launches sales. The next stage will be certification in China, Japan, Singapore.
07.07.2017We present to your attention the traditional semi-annual review of the most important news of the pharmaceutical industry and medical biotech, prepared by expert Ilya Yasny.
04.07.2017Nikolay Dobrovolsky, Vice President of Parallels: venture business is like a lottery. Few are lucky. How not to discover that you are developing a startup for the sake of a startup?
14.06.2017Professor Gainetdinov is a vivid example of how the grant system helps to develop Russian science and involve truly talented creators in it.
29.05.2017GenerationS partner corporations have chosen the accelerator as a platform for implementing their own innovative programs and developing "open innovation" tools.
29.05.2017In many countries, mass genetic screening projects are already improving the situation with hereditary diseases. What are the prospects for such scenarios for Russia?
22.05.2017Currently, targeted drug delivery is developing especially rapidly from all areas of nanomedicine, and large amounts of funding will be allocated for this.
22.05.2017This is one of the first laboratories in Russia that will operate in accordance with the requirements of the law on biomedical cell products.
19.05.2017DRD company from the Republic of Buryatia and nine other residents of the Skolkovo Foundation took part in the TechCrunch innovation exhibition in New York.
18.05.2017The new technology makes it possible to make the processes of selection, storage and transportation of blood and biological fluid samples simpler, more reliable and cheaper.
17.05.2017Now chlorella is grown in Russia, but it takes at least a day. In a bioreactor developed at TPU, 12 hours are enough to obtain the desired concentration.
28.04.2017The blood substitute developed by Kaluga scientists has become a priority project of the Ministry of Defense and can be included in the reserves of the state reserve in case of war, terrorist attacks and disasters.
10.04.2017The first robotic surgical complex of domestic production was presented in Moscow. The creators call it the answer to the American robot Da Vinci.
07.04.2017The Russian Venture Investment Association presents an annual Review of the Russian direct and venture investment market, prepared by RAVI with the support of RVC.
07.04.2017PricewaterhouseCoopers and the Russian Venture Company present the sixth annual review of the Russian venture industry "MoneyTreeTM: Navigator of the Venture Market" for 2016.
28.03.2017The law regulating the use of cellular technologies: the beginning of a new industry, simplification of interaction between the medical and business communities, or complication of work?
22.03.2017Business innovation activity in Russia continued to decline in 2015: innovation costs in all industries, except telecom and IT, decreased by 10.5% in 1995 prices.
16.03.2017Novosibirsk researchers have found a way to diagnose malignant tumors at an early stage at the molecular genetic level. But there is no money for its implementation.
16.03.2017The article, published by TPU scientists together with Russian and foreign co-authors, was included in the top 5 most widely read publications of the journal Advanced Healthcare Materials.
03.03.2017You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.